SE9202318D0 - NEW PEPTIDES, DIAGNOSTIC ANTIGEN, USE THEREOF, VACCINES AND MEDICINES - Google Patents

NEW PEPTIDES, DIAGNOSTIC ANTIGEN, USE THEREOF, VACCINES AND MEDICINES

Info

Publication number
SE9202318D0
SE9202318D0 SE9202318A SE9202318A SE9202318D0 SE 9202318 D0 SE9202318 D0 SE 9202318D0 SE 9202318 A SE9202318 A SE 9202318A SE 9202318 A SE9202318 A SE 9202318A SE 9202318 D0 SE9202318 D0 SE 9202318D0
Authority
SE
Sweden
Prior art keywords
peptides
vaccines
medicines
medicaments
new peptides
Prior art date
Application number
SE9202318A
Other languages
Swedish (sv)
Other versions
SE9202318L (en
Inventor
J Blomberg
Original Assignee
Replico Medical Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Replico Medical Ab filed Critical Replico Medical Ab
Priority to SE9202318A priority Critical patent/SE9202318L/en
Publication of SE9202318D0 publication Critical patent/SE9202318D0/en
Priority to AU47670/93A priority patent/AU4767093A/en
Priority to PCT/SE1993/000671 priority patent/WO1994003493A1/en
Publication of SE9202318L publication Critical patent/SE9202318L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Abstract

Peptides, XLQNXXXLXLLTAXKGGLXXFLNEE and shorter variants thereof with at least 6 aminoacids of this sequence, diagnostic antigens containing said peptides or antibodies against said peptides, a method of antibody purification, immunoassay methods, a vaccine composition containing said peptides and medicaments containing said peptides or antibodies against said peptides are provided. The immunoassay methods permit detection of retroviral transmembrane proteins, or of desease caused by certain retroviruses. The medicaments can induce immunosuppression and thereby facilitate transplantation, or inhibit the immunosuppression occurring in certain diseases. The vaccine can protect against disease associated with certain retroviruses.
SE9202318A 1992-08-10 1992-08-10 New peptides, diagnostic antigens, their use, vaccines and drugs SE9202318L (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
SE9202318A SE9202318L (en) 1992-08-10 1992-08-10 New peptides, diagnostic antigens, their use, vaccines and drugs
AU47670/93A AU4767093A (en) 1992-08-10 1993-08-08 Peptides derived from an immunosuppressive region in the retroviral genome
PCT/SE1993/000671 WO1994003493A1 (en) 1992-08-10 1993-08-08 Peptides derived from an immunosuppressive region in the retroviral genome

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9202318A SE9202318L (en) 1992-08-10 1992-08-10 New peptides, diagnostic antigens, their use, vaccines and drugs

Publications (2)

Publication Number Publication Date
SE9202318D0 true SE9202318D0 (en) 1992-08-10
SE9202318L SE9202318L (en) 1994-02-11

Family

ID=20386905

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9202318A SE9202318L (en) 1992-08-10 1992-08-10 New peptides, diagnostic antigens, their use, vaccines and drugs

Country Status (3)

Country Link
AU (1) AU4767093A (en)
SE (1) SE9202318L (en)
WO (1) WO1994003493A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002511277A (en) * 1998-04-08 2002-04-16 エムエス・リサーチ・アクティーゼルスカブ Diagnosis of multiple sclerosis and other demyelinating diseases

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4794168A (en) * 1984-04-24 1988-12-27 Scripps Clinic And Research Foundation Leukemia-associated virus immunogen, vaccine and assay
US4822606A (en) * 1986-04-07 1989-04-18 Duke University Immunosuppressive synthetic peptides and analogs thereof based on retroviral envelope sequences
US4833071A (en) * 1987-01-09 1989-05-23 United Biomedical, Inc. Peptide composition as anitgen for detection of antibodies to HTLV-I, as a vaccine for ATL and methods therefor
EP0300031A4 (en) * 1987-01-28 1990-05-14 Ortho Pharma Corp Immunosuppressive peptides and methods of use.
US5017687A (en) * 1988-03-10 1991-05-21 Virovahl, S.A. Peptides for the detection of HTLV-1 infection
SE8900721D0 (en) * 1989-03-02 1989-03-02 Blomberg Jonas METHODS FOR DETECTION OF ANTIBODIES TO
JP2807287B2 (en) * 1989-10-13 1998-10-08 株式会社医学生物学研究所 Peptides and their uses

Also Published As

Publication number Publication date
WO1994003493A1 (en) 1994-02-17
AU4767093A (en) 1994-03-03
SE9202318L (en) 1994-02-11

Similar Documents

Publication Publication Date Title
NO20002413D0 (en) Antibodies to Moraxella proteins and their use, as well as sets for the detection of antigen and pharmaceutical preparations containing antibodies
WO1996029605A3 (en) Compounds and methods for the dectection of t. cruzi infection
DK0523395T3 (en) Seroreactive regions on proteins E1 and E2 in HPV 16
EP0284587A3 (en) Synthetic peptide antigens for the detection of hiv-1 infection
ATE132197T1 (en) MONOCLONAL ANTIBODIES
EP0090581A3 (en) Small peptides with the specificity of foot and mouth disease viral antigens
EE03287B1 (en) T-cell antigen receptor V region proteins, methods for their preparation, expression vector and bacterial cell for their preparation, pharmaceutical composition containing them, their use in the manufacture of medicaments and diagnostic methods.
DE69322872T2 (en) VACCINE AGAINST THE CAT'S IMMUNODEFICIENCY VIRUS (KIV)
WO1996021734A3 (en) P15 and tyrosinase melanoma antigens and their use in diagnostic and therapeutic methods
ATE122394T1 (en) PANCREATIC ISLE CELL ANTIGENS OBTAINED BY MOLECULAR CLONING.
BR9106159A (en) SYNTHETIC POLYPEPTIDE, VACCINE, CASE TO DETECT HIV OR HIV ANTIBODIES, DNA MOLECULE, PHARMACEUTICAL COMPOSITION, ANTIBODY OR FRAGMENT OF THE SAME ANTIGEN, THERAPY PROCESSES OR HIV INFECTION, PROTECTING HIV AND HIV INFECTION, PROTECTING HIV THE MANUFACTURE OF A SYNTHETIC POLYPEPTIDE, PHARMACEUTICAL COMPOSITION AND AN ANTIBODY OR BINDING FRAGMENT OF THE SAME
SE9202968L (en) New peptides, diagnostic antigens, their use, vaccines and drugs
DE3782771D1 (en) AGAINST PSEUDOMONAS AERUGINOSA INFECTIONS EFFECTIVE PREPARATIONS AND METHOD FOR THEIR PRODUCTION.
ATE94880T1 (en) SYNTHETIC PEPTIDES, ANTIBODIES DIRECTED AGAINST THEM AND THEIR USE.
ES2087111T3 (en) SYNTHETIC VACCINE FOR THE SPECIFIC INDUCTION OF T CYTOTOXIC LYMPHOCYTES.
ATE375514T1 (en) COMPOSITIONS AND METHODS FOR DETECTING TRYPANOSOMA CRUZI INFECTION
JPS6463392A (en) Monoclonal antibody against specific antigen for human immunodeficiency virus
DE68923286T2 (en) Vaccines and test kits for Haemophilus Influenza.
SE9202318D0 (en) NEW PEPTIDES, DIAGNOSTIC ANTIGEN, USE THEREOF, VACCINES AND MEDICINES
RU94040393A (en) Synthetic peptides for vaccine against german measles
EP0293827A3 (en) Assay for leishmaniasis
ATE142262T1 (en) IMMUNE PREPARATION DIRECTED AGAINST THE HUMAN IMMUNO DEFICIENCY VIRUS
DE69311796D1 (en) PEPTIDES OF THE CASEINOMACROPEPTID, ANTIBODIES AGAINST IT AND THEIR APPLICATIONS
Williams et al. Lymphocyte antigens in systemic lupus erythematosus: studies with heterologous antisera.
FI910587A0 (en) SYNTHETIC POLYPEPTIDER OCH ANTIKROPPAR, VILKA HAENFOER SIG TILL EPSTEIN-BARR VIRUSETS NUCLEAERA ANTIGEN.

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 9202318-3